[HTML][HTML] Clinical and genetic aspects of neurofibromatosis 1

K Jett, JM Friedman - Genetics in Medicine, 2010 - Elsevier
Neurofibromatosis 1 is an autosomal dominant disorder characterized by multiple café-au-
lait spots, axillary and inguinal freckling, multiple cutaneous neurofibromas, and iris Lisch …

Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options

F Elefteriou, M Kolanczyk, A Schindeler… - American journal of …, 2009 - Wiley Online Library
The skeleton is frequently affected in individuals with neurofibromatosis type 1, and some of
these bone manifestations can result in significant morbidity. The natural history and …

Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)

T Tucker, C Schnabel, M Hartmann… - Journal of medical …, 2009 - jmg.bmj.com
Background: Patients with neurofibromatosis 1 (NF1) are shorter than expected and often
have low bone mineral density (BMD), but the pathogenesis of these bony problems is …

Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1

J de la Croix Ndong, AJ Makowski, S Uppuganti… - Nature medicine, 2014 - nature.com
Individuals with neurofibromatosis type-1 (NF1) can manifest focal skeletal dysplasias that
remain extremely difficult to treat. NF1 is caused by mutations in the NF1 gene, which …

Progressive bone impairment with age and pubertal development in neurofibromatosis type I

G Rodari, G Scuvera, FM Ulivieri, E Profka… - Archives of …, 2018 - Springer
Bone density impairment represents an established complication in adults with
neurofibromatosis type 1, while few data exist in the pediatric population. Age-and gender …

Alkaline phosphatase replacement therapy for hypophosphatasia in development and practice

SA Bowden, BL Foster - Therapeutic Enzymes: Function and Clinical …, 2019 - Springer
Hypophosphatasia (HPP) is an inherited disorder that affects bone and tooth mineralization
characterized by low serum alkaline phosphatase. HPP is caused by loss-of-function …

Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels

M Delagrange, V Rousseau, C Cessans, C Pienkowski… - Bone, 2021 - Elsevier
Although musculoskeletal abnormalities have long been described in patients with Noonan
syndrome (NS), only a few studies have investigated the bone status of these patients. The …

Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1

AM Gross, SR Plotkin, NB Watts, MJ Fisher… - Clinical …, 2024 - journals.sagepub.com
Neurofibromatosis type 1 is a genetic syndrome characterized by a wide variety of tumor and
non-tumor manifestations. Bone-related issues, such as scoliosis, tibial dysplasia, and low …

Bone mineral density, vitamin D and osseous metabolism indices in neurofibromatosis type 1: A systematic review and meta-analysis

A Kaspiris, E Vasiliadis, ID Iliopoulos, F Panagopoulos… - Bone, 2024 - Elsevier
Abstract Background Neurofibromatosis type 1 (NF1) is a genetic autosomal
neurocutaneous syndrome correlated with skeletal dysplasia and defects in the osseous …

Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity

UP Ferrara, C Tortora, C Rosano, A Assunto… - Scientific Reports, 2022 - nature.com
Bone metabolism has been rarely investigated in children affected by Neurofibromatosis
type 1 (NF1). Aim of the present study was to assess bone mineral metabolism in children …